1.Wolves Trapped in the NETs–The Pathogenesis of Lupus Nephritis.
Journal of Rheumatic Diseases 2018;25(2):81-99
Systemic lupus erythematous (SLE) is a systemic autoimmune disease with multi-organ inflammation caused by the production of pathogenic autoantibodies and immune complexes reflecting a global loss of tolerance. Lupus nephritis (LN) is present in approximately 60% of SLE patients and is considered a major predictor of a poor prognosis. To date, many studies utilizing genomics, transcriptomics, epigenetics, metabolomics, and microbiome have been conducted on a range of animal models and lupus patients to understand the pathogenesis of SLE and LN. Collectively, these studies support the concept that LN is caused by increased cell death, which has not been properly dealt with; abnormal innate immunity; hyperactive adaptive immunity; and genetic variants triggered by a range of environmental factors. This review summarizes the results from studies that contributed strongly to elucidating the pathogenesis of SLE and LN, highlighting the immunological and non-immunological mechanisms.
Adaptive Immunity
;
Allergy and Immunology
;
Antigen-Antibody Complex
;
Apoptosis
;
Autoantibodies
;
Autoimmune Diseases
;
Cell Death
;
Epigenomics
;
Genomics
;
Humans
;
Immunity, Innate
;
Inflammation
;
Lupus Nephritis*
;
Lymphocytes
;
Metabolomics
;
Microbiota
;
Models, Animal
;
Prognosis
;
Wolves*
2.Two Cases of Allergic Reactions to Mesna which Imitate Malar Rash.
Jeong Cheol SEO ; Sang Cheol BAE ; Seung Cheol SHIM ; Tae Hwan KIM ; Jae Bum JUN ; Sung Soo JUNG ; In Hong LEE ; Dae Hyun YOO ; Seong Yoon KIM
The Journal of the Korean Rheumatism Association 2000;7(2):196-199
Hemorrhagic cystitis is potentially life-threatening sequellae of chemotherapy using oxazaphosphorine alkylating agents (cyclophosphamide and ifosfamide). Mesna contains a sulfhydryl group that is believed to bind acrolein within the urinary collecting system and reduce the hemorrhagic cystitis without affecting the chemotherapeutic potential. To date, about thirty cases of hypersensitivity or allergic reactions of the delayed and urticarial type associated with mesna have been reported. We reported two patients with systemic lupus erythematosus who developed facial rash and flushing associated with mesna which imitate malar rash.
Acrolein
;
Alkylating Agents
;
Cyclophosphamide
;
Cystitis
;
Drug Therapy
;
Exanthema*
;
Flushing
;
Humans
;
Hypersensitivity*
;
Lupus Erythematosus, Systemic
;
Mesna*
3.Role of T lymphocyte in the pathogenesis of rheumatoid arthritis.
Seung Cheol SHIM ; Mi Kyoung LIM ; Dong Hyuk SHEEN
Hanyang Medical Reviews 2005;25(2):26-35
PURPOSE OF REVIEW: Rheumatoid arthritis (RA) is characterized by a chronic T-cell response that has escaped normal control mechanisms. This review summarizes recent insights in pathways that are functional in RA and that favor continuous and pathogenic T-cell activation. RECENT FINDINGS: T-cell activation is ultimately determined by positive signals from costimulatory molecules and negative signals from regulatory T cells. Blockade of the classic costimulatory pathway, CD28-CD80 or CD86, is beneficial in RA. Additional pathways that predominantly control the activation of memory and effector T cells are functionally important in synovial inflammation. Some of these costimulatory molecules(such as stimulatory killer cell immunoglobulin-like receptors and NKG2D) appear to be relatively specific for RA and not to play a role in normal immune responses. In addition to this predominance of positive signals, age-disproportionate decline in thymic activity in RA may lead to a diminution of regulatory T cells and loss of their negative signals. SUMMARY: The successful treatment trial of RA with CTLA-4Ig clearly documents the importance of T-cell costimulation in RA disease activity. Novel costimulatory pathways may be of even greater significance than CD28 in RA and may represent promising new therapeutic targets. The finding of reduced thymic activity in RA is exciting and will stimulate further studies of T-cell homeostasis and the function of regulatory cells.
Arthritis, Rheumatoid*
;
Autoimmunity
;
Homeostasis
;
Inflammation
;
Lymphocytes*
;
Memory
;
Receptors, KIR
;
T-Lymphocytes
;
T-Lymphocytes, Regulatory
;
United Nations
4.Immediate Results of AVE Micro-II Stent.
Jong Cheol RYU ; Yangsoo JANG ; Keun Young KIM ; Seung Hwan LEE ; Jong Huyn KIM ; Dong Woon JEON ; Won Heum SHIM ; Seung Yun CHO ; Hongkeun CHO
Korean Circulation Journal 1997;27(5):532-540
BACKGROUND: Several kinds of stents have shown their safety and efficacy to treat acute or subacute closure after balloon angioplasty as well as to reduce restenosis rate. However, one of the limitations of stents is difficult to deploy especially in tortuos vessels, lesions at a bend, and distal to previously deployed stents. The Micro stent II, which was one of the most recently developed stents, ia a rapid-exchage balloon expandable stainless steel stent with a zigzag design connected with a continuous single weld in each 3mm segments. It scores over excellent trackability and optimum radio-opacity. Therefore, it is easy to operate and feasible in tortuous, distal lesions and variety of lesion lengths. We report our experiences with Micro-II stent implanatation in the first 76 patients at Tonsei cardiovascular center to assess its safety and efficacy in patients with complex coronary anatomy and clinical results in the first months. METHODS: Between January 1996 and July 1996, eighty-six Micro-II stent were implanted in the coronary arteries of 76 patients(male 65.8%, age 59+/-10 year). Forty-five patients had unstable angina, the others had stable angina(17pts), acute myocardial infarction(14pts). RESULTS: 1) Indication of stenting was de novo 51(59.3%), suboptimal result 25(29.1%), restenosis 1(1.2%) and 9(10.4%) of lesions were stented in bail out situation. 2) Single stent were implanted in 76(88.4%)lesions, overlapping stent in 10(11.6%)lesions. Among overlapping stents, the second stent with Micro-II stent and with another kind of stent were 4.6%, 7.0%, respectively. 3) Procedure related complication including a subacute closure was occurred in 1(1.2%) patient who had distal dissection and 45% residual stenosis. In 12(14%) lesions, preistent dissection has been noticed after stent impantation. 4) Angiographic success(defined as a residual stenosis of <30% without major dissection) was achieved in 82 of 86 attempts(95.3%). The procedual success rate(defined as a residual stenosis of <30% without occurrence of major clinical events within 4 weeks after procesure) was 96.1%(73/76 patients). Angiographic success and procedural success rate in calcified lesion were 100% and 100%, respectively. Angiographic success and procedural success rate in more than 45` angulated lesion were 97% and 100%, respectively. 5) The mean minimal luminal diameter of the target lesions was increased from 0.42+/-0.40mm before stent implantation to 2.93+/-0.50mm(p<0.001). The percentage of diameter stenosis was reduced from 86.49+/-13.04% to 1.40+/-7.11%(p<0.001) after stent implantation. CONCLUSION: Coronary stenting with AVE Micro-II stent can be safety performed and is particularly beneficial in tortuous and calcified arteries. There was a high tendency for peristent dissection which need to special consideration to avoid. Follow-up data is needed to assess mid and term patency. Coronary artery disease . AVE Micro-II stent . Immediate results.
Angina, Unstable
;
Angioplasty, Balloon
;
Arteries
;
Constriction, Pathologic
;
Coronary Artery Disease
;
Coronary Vessels
;
Follow-Up Studies
;
Humans
;
Phenobarbital
;
Stainless Steel
;
Stents*
6.Novel Pharmacologic Therapies in the Treatment of Systemic Lupus Erythematosus.
Hanyang Medical Reviews 2012;32(2):83-93
Systemic lupus erythematosus (lupus) is an autoimmune disease that affects primarily women, especially those of reproductive age. Lupus is a prototypic organ non-specific autoimmune disease that may affect any organ in the body resulting in displaying a broad spectrum of clinical and immunological manifestations. The pathogenesis of lupus involves a complex interplay between genetic and environmental factors and the adaptive and innate immune systems. Defects in central and peripheral tolerance, increased antigenic load, excess T-cell help, B cell hyperactivity, autoantibody production and cytokine imbalance, ultimately lead to immune-complex formation and complement activation causing immunologically mediated organ damage, culminating in premature death. There is an urgent need for the development of novel agents since many patients are refractory to traditional agents. However, there are two hurdles that make development of new therapeutic agents difficult. First, we do not understand the whole picture of the pathogenesis of lupus because of its complex and multi-systemic presentation. Secondly, lupus lacks a reliable and sensitive biomarker for measuring disease activity, and a standardized method for defining response to therapy. Nevertheless, great advances have been made during the past 10 years because of the great efforts of basic researchers and clinicians on elucidating the cause of the disease, and participation of pharmaceutical and biotechnical companies in the development of novel agents. My goal was to evaluate the efficacy and safety of novel pharmaceutical agents by a comprehensive review of open-label and randomized clinical trials conducted in patients with lupus.
Autoimmune Diseases
;
Biological Agents
;
Complement Activation
;
Female
;
Humans
;
Immune System
;
Lupus Erythematosus, Systemic
;
Mortality, Premature
;
Peripheral Tolerance
;
Pharmaceutical Services
;
T-Lymphocytes
7.Diagnostic Performances of Anti-Cyclic Citrullinated Peptides Antibody and Antifilaggrin Antibody in Korean Patients with Rheumatoid Arthritis.
Suk Woo CHOI ; Mi Kyoung LIM ; Dong Hyuk SHIN ; Jeong Jin PARK ; Seung Cheol SHIM
Journal of Korean Medical Science 2005;20(3):473-478
Rheumatoid arthritis (RA) is a systemic autoimmune disease of unknown etiology. We studied the diagnostic performances of anti-cyclic citrullinated peptides antibody (anti-CCP) assay and recombinant anti-citrullinated filaggrin antibody (AFA) assay by enzyme linked immunosorbent assay (ELISA) in patients with RA in Korea. Diagnostic performances of the anti-CCP assay and AFA assay were compared with that of rheumatoid factor (RF) latex fixation test. RF, anti-CCP, and AFA assays were performed in 324 RA patients, 251 control patients, and 286 healthy subjects. The optimal cut off values of each assay were determined at the maximal point of area under the curve by receiver-operator characteristics (ROC) curve. Sensitivity (72.8%) and specificity (92.0%) of anti-CCP were better than those of AFA (70.3%, 70.5%), respectively. The diagnostic performance of RF showed a sensitivity of 80.6% and a specificity of 78.5%. Anti-CCP and AFA showed positivity in 23.8% and 17.3% of seronegative RA patients, respectively. In conclusion, we consider that anti-CCP could be very useful serological assay for the diagnosis of RA, because anti-CCP revealed higher diagnostic specificity than RF and AFA at the optimal cut off values and could be performed by easy, convenient ELISA method.
Adolescent
;
Adult
;
Aged
;
Antibodies/*diagnostic use/immunology
;
Arthritis, Rheumatoid/*diagnosis/immunology
;
Comparative Study
;
Enzyme-Linked Immunosorbent Assay/methods
;
Female
;
Humans
;
Intermediate Filament Proteins/*immunology
;
Korea
;
Male
;
Middle Aged
;
Peptides, Cyclic/*immunology
;
Research Support, Non-U.S. Gov't
;
Rheumatoid Factor/immunology
;
Sensitivity and Specificity
8.Withdrawal: Animal Models in Systemic Lupus Erythematosus.
Hyo PARK ; Dong Hyuk SHEEN ; Mi Kyoung LIM ; Seung Cheol SHIM
Journal of Rheumatic Diseases 2014;21(6):343-343
This article has been retracted.
9.Clinical Observation of Endoscopic Gastrointestinal Polypectomies.
Seung Cheol SHIM ; Seok Jin YOON ; Joon Soo HAHM ; Jong Chul RHEE ; Min Ho LEE ; Choon Suhk KEE ; Kyung Nam PARK
Korean Journal of Gastrointestinal Endoscopy 1993;13(2):381-388
Advances in fiberoptic endoscopy have improved diagnostic capabilities and management in piatients with gastrointestinal polyps. The gastrointestinal polyp is a premalignant lesion in varying degrees, according to size, pathology, and location. Endoscopic polypectomy has long been considered as a safe and effective method for removal of polyps. Sixty endoscopic gastrointestinal polypectomies were done in 53 patients who visited Hanyang University Hospital from 1984 to l990, and the clinical characteristics including histopathalogy were evaluated. (continue...)
Endoscopy
;
Humans
;
Pathology
;
Polyps
10.5-azacytidine induces cardiac differentiation of P19 embryonic stem cells.
Seung Cheol CHOI ; Ji hyun YOON ; Wan Joo SHIM ; Young Moo RO ; Do Sun LIM
Experimental & Molecular Medicine 2004;36(6):515-523
The P19 embryonal carcinoma cell line is a useful model cells for studies on cardiac differentiation. However, its low efficacy of differentiation hampers its usefulness. We investigated the effect of 5-azacytidine (5-aza) on P19 cells to differentiate into a high-efficacy cardiomyocytes. Embryoid-body-like structures were formed after 6 days with 1 micrometer of 5-aza in a P19 cell monolayer culture, beating cell clusters first observed on day 12, and, the production of beating cell clusters increased by 80.1% (29 of 36-wells) after 18 days. In comparison, the spontaneous beating cells was 33.3% (12 of 36-wells) for the untreated control cells. In response to 1 micrometer of 5-aza, P19 cells expressed bone morphogenetic protein-2 (BMP-2), BMP-4, Bmpr1a and Smad1 at day 6 or 9, and also cardiac markers such as GATA-4, Nkx2.5, cardiac troponin I, and desmin were up-regulated in a time-dependent manner after induction of BMP signaling molecules. Immunocytochemistry revealed the expression of smooth muscle a-actin, sarcomeric a-actinin, cardiac myosin heavy chain, cardiac troponin T and desmin, respectively. The proportion of sarcomeric a-actinin positive cells accounted for 6.48% on day 15 after 5-aza exposure as measured by flow cytometry. This study has demonstrated that 5-aza induces differentiation of P19 cells into cardiomyocytes in a confluent monolayer culture in the absence of prior embryoid formation and dimethyl sulfoxide exposure, depending in part on alteration of BMP signaling molecules. These results suggest that 5-aza treatment could be used as a new method for cardiac differentiation in P19 cells.
Animals
;
Azacitidine/*pharmacology
;
Bone Morphogenetic Proteins/genetics/metabolism
;
Cell Differentiation/drug effects/genetics
;
Cell Line, Tumor
;
Cell Proliferation/drug effects
;
DNA-Binding Proteins/genetics/metabolism
;
Embryo/cytology
;
Gene Expression
;
Homeodomain Proteins/genetics/metabolism
;
Mice
;
Muscle Proteins/analysis/genetics/metabolism
;
Myocytes, Cardiac/*cytology/immunology/physiology
;
Research Support, Non-U.S. Gov't
;
Stem Cells/*drug effects/metabolism
;
Transcription Factors/genetics/metabolism